Hikma Pharmaceuticals (LON:HIK) Share Price Passes Above Two Hundred Day Moving Average – Here’s What Happened

Hikma Pharmaceuticals PLC (LON:HIK)’s stock price crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 2,014.14 ($26.79) and traded as high as GBX 2,040 ($27.14). Hikma Pharmaceuticals shares last traded at GBX 2,004 ($26.66), with a volume of 244,540 shares traded.

Analysts Set New Price Targets

A number of research analysts have commented on HIK shares. Berenberg Bank restated a “buy” rating and issued a GBX 2,560 ($34.06) price objective on shares of Hikma Pharmaceuticals in a research note on Monday, March 10th. JPMorgan Chase & Co. reaffirmed an “overweight” rating on shares of Hikma Pharmaceuticals in a research note on Friday, March 7th.

Hikma Pharmaceuticals Trading Down 1.0 %

The company has a fifty day moving average of GBX 1,964.11 and a two-hundred day moving average of GBX 2,014.14. The company has a quick ratio of 1.27, a current ratio of 1.66 and a debt-to-equity ratio of 55.82. The stock has a market capitalization of £5.56 billion, a price-to-earnings ratio of 19.66, a P/E/G ratio of 2.38 and a beta of 0.41.

Hikma Pharmaceuticals Increases Dividend

The company also recently announced a dividend, which was paid on Thursday, May 1st. Stockholders of record on Thursday, March 20th were paid a $0.48 dividend. This represents a dividend yield of 1.8%. The ex-dividend date was Thursday, March 20th. This is a boost from Hikma Pharmaceuticals’s previous dividend of $0.32. Hikma Pharmaceuticals’s dividend payout ratio (DPR) is 60.84%.

Insider Transactions at Hikma Pharmaceuticals

In related news, insider Victoria Hull sold 2,777 shares of Hikma Pharmaceuticals stock in a transaction that occurred on Tuesday, April 8th. The stock was sold at an average price of GBX 1,800 ($23.95), for a total value of £49,986 ($66,497.27). Company insiders own 30.54% of the company’s stock.

Hikma Pharmaceuticals Company Profile

At Hikma we help put better health within reach, every day. By creating high-quality medicines and making them accessible to the people who need them, we help to shape a healthier world that enriches all our communities. We help deliver this by living our culture, delivering our strategy, and acting responsibly.